Takeda Allocates $22.2M to Four CSR Partners for Climate-Resilient Health Systems
Event summary
- Takeda awarded $22.2M to four partners in 2026 to advance climate-resilient health systems in low- and middle-income countries.
- Funding includes $6.4M to Corus International for disaster preparedness in Nepal, $6.1M to Humanity & Inclusion for workforce capacity in Honduras and Peru, $5.1M to KNUST for pharmacy workforce training in Ghana, and $4.6M to Terre des hommes for healthcare facility retrofits in Egypt and Lebanon.
- Program aligns with Takeda’s purpose of improving health and addressing climate change impacts on healthcare access.
- Partnerships focus on locally led solutions to strengthen health infrastructure and improve patient outcomes.
The big picture
Takeda’s $22.2M investment underscores the growing intersection of climate change and healthcare access, particularly in vulnerable regions. As extreme weather events disrupt health systems, pharmaceutical companies are increasingly funding locally led solutions to strengthen resilience. This move aligns with broader industry trends where corporations are extending their ESG commitments beyond traditional environmental efforts to include social and governance impacts on health.
What we're watching
- Impact Measurement
- How Takeda will track and report the effectiveness of these partnerships in improving climate-resilient health systems.
- Scalability
- Whether the early warning models and health facility adaptations can be replicated in other regions.
- Regulatory Alignment
- The pace at which global health policies will integrate climate resilience into healthcare infrastructure standards.
Related topics